Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Islet autoimmunity has long been recognized in the pathogenesis of type 1 diabetes and is becoming increasingly acknowledged as a component in the pathogenesis of type 2 diabetes. Islet reactive T cells and autoantibodies have been demonstrated in type 1 diabetes, whereas islet autoimmunity in type 2 diabetes has been limited to islet autoantibodies. In this study, we investigated whether islet reactive T cells might also be present in type 2 diabetic patients and how islet reactive T cells correlate with β-cell function. RESEARCH DESIGN AND METHODS: Adult phenotypic type 2 diabetic patients (n = 36) were screened for islet reactive T-cell responses using cellular immunoblotting and five islet autoantibodies (islet cell antibody, GADA, insulin autoantibody, insulinoma-associated protein-2 autoantibody, and zinc transporter autoantibody). RESULTS: We identified four subgroups of adult phenotypic type 2 diabetic patients based on their immunological status (Ab−T−, Ab+T−, Ab−T+, and Ab+T+). The Ab−T+ type 2 diabetic patients demonstrated T-cell responses similar to those of the Ab+T+ type 2 diabetic patients. Data were adjusted for BMI, insulin resistance, and duration of diabetes. Significant differences (P < 0.02) were observed among groups for fasting and glucagon-stimulated C-peptide responses. T-cell responses to islet proteins were also demonstrated to fluctuate less than autoantibody responses. CONCLUSIONS: We have identified a group of adult autoimmune phenotypic type 2 diabetic patients who are Ab−T+ and thus would not be detected using autoantibody testing alone. We conclude that islet autoimmunity may be more prevalent in adult phenotypic type 2 diabetic patients than previously estimated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Staggeringly, islet reactive T-cells were found in 72% of phenotypic T2D patients that participated in one study, which was an unexpected finding, especially as great care was taken to select patients that had minimal chance of being misdiagnosed with T2D and have T1D”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [315]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Principles and Practice of Medical Genetics
Pembrey, M. (1984) · Archives of Disease in Childhood · doi:10.1136/adc.59.2.192 · Cited by 776
Yu, L., Robles, D. T., Abiru, N., Kaur, P., Rewers, M., Kelemen, K., & Eisenbarth, G. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556697 · Cited by 450 · cited 1×
“IAA was measured by a micro-radiobinding assay as previously described (20).”
Islet Inflammation in Type 2 Diabetes
Donath, M. Y., Schumann, D. M., Faulenbach, M., Ellingsgaard, H., Perren, A., & Ehses, J. A. (2008) · Diabetes Care · doi:10.2337/dc08-s243 · Cited by 334 · cited 1×
“diabetes includes the presence of cytokines (2, 3) and the infiltration of immune cells (3,4).”
Principles and Practice of Medical Genetics.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-817_2 · Cited by 290
Greenbaum, C. J., Mandrup-Poulsen, T., McGee, P. F., Battelino, T., Haastert, B., Ludvigsson, J., Pozzilli, P., Lachin, J. M., Kolb, H., & The Type 1 Diabetes Trial Net Research Group and the European C-Peptide Trial Study Group (2008) · Diabetes Care · doi:10.2337/dc07-2451 · Cited by 285
Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., & Laboratories, P. (2008) · Diabetologia · doi:10.1007/s00125-008-0967-2 · Cited by 284
Islet-associated macrophages in type 2 diabetes
Richardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Diabetologia · doi:10.1007/s00125-009-1410-z · Cited by 239
Antiislet autoantibodies usually develop sequentially rather than simultaneously
Yu, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4264 · Cited by 214 · cited 6×
“Liping Yu and George Eisenbarth at the Barbara Davis Center (19).”
InfluentialTransfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation
Lampeter, E. F., Homberg, M., Gries, F. A., Kolb, H., Quabeck, K., Schaefer, U. W., Wernet, P., Grosse-Wilde, H., & Bertrams, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91148-f · Cited by 213
Falorni, A., Örtqvist, E., Persson, B., & Lernmark, Å. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00139-2 · Cited by 195 · cited 2×
“Autoantibodies to IA-2 were measured under identical conditions as described for GADA (14) using the plasmid containing the cDNA”
Schatz, D., Krischer, J., Horne, G., Riley, W., Spillar, R., Silverstein, J., Winter, W., Muir, A., Derovanesian, D., & Shah, S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117247 · Cited by 134
Wang, J., Miao, D., Babu, S. R., Yu, J., Barker, J. M., KLINGENSMITH, G. J., Rewers, M., Eisenbarth, G. S., & Yu, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1494 · Cited by 125 · cited 3×
“diabetes has been linked to increasing age at diagnosis of patients as well as increasing time from diagnosis (7).”
InfluentialJuneja, R., Hirsch, I. B., Naik, R. G., Brooks‐Worrell, B., Greenbaum, C. J., & Palmer, J. P. (2001) · Metabolism · doi:10.1053/meta.2001.25654 · Cited by 99
Self-citationPancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction
Ehses, J. A., Ellingsgaard, H., Böni-Schnetzler, M., & Donath, M. Y. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903025879 · Cited by 97
Herold, K. C., Brooks‐Worrell, B., Palmer, J. P., Dosch, H., Peakman, M., Gottlieb, P. A., Reijonen, H., Arif, S., Spain, L. M., Thompson, C. M., et al. (2009) · Diabetes · doi:10.2337/db09-0249 · Cited by 92
Self-citationAnalysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes
Seyfert‐Margolis, V., Gisler, T. D., Asare, A. L., Wang, R. S., Dosch, H., Brooks‐Worrell, B., Eisenbarth, G. S., Palmer, J. P., Greenbaum, C. J., Gitelman, S. E., et al. (2006) · Diabetes · doi:10.2337/db05-1378 · Cited by 88
Self-citationCellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients.
Brooks-Worrell, B. M., Juneja, R., Minokadeh, A., Greenbaum, C. J., & Palmer, J. P. (1999) · Diabetes · doi:10.2337/diabetes.48.5.983 · Cited by 87
Self-citationDistinct Genetic and Immunological Features in Patients With Onset of IDDM Before and After Age 40
Lohmann, T., Sessler, J., Verlohren, H.-J., Schröder, S., Rötger, J., Dãhn, K., Morgenthaler, N. G., & Scherbaum, W. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.524 · Cited by 80 · cited 1×
“process in autoimmune diabetes involves Tcells, immune markers of autoimmune diabetes have primarily centered on the presence of circulating serum autoantibodies to various islet antigens (5, 6).”
Brooks‐Worrell, B., Starkebaum, G. A., Greenbaum, C. J., & Palmer, J. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5668 · Cited by 67 · cited 1×
“The specificity of the Tcell responses from diabetic patients to islet proteins has been demonstrated previously (11).”
Self-citationGoel, A., Chiu, H., Felton, J., Palmer, J. P., & Brooks-Worrell, B. (2007) · Diabetes · doi:10.2337/db06-0552 · Cited by 59
Self-citationRowe, R. E., Leech, N., Nepom, G., & Mcculloch, D. (1994) · Diabetes · doi:10.2337/diab.43.1.87 · Cited by 41 · cited 2×
“ICA assay This assay was performed as described previously (17).”
Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E. E., Bingley, P. J., & Giordano, C. S. D. S. (2008) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 31
Autoimmune diabetes in adults: lessons from the UKPDS
Desai, M., & Clark, A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02497.x · Cited by 27 · cited 1×
“The existence of the Ab T type 2 diabetic patients is extremely important because many larger studies, such as the UK Prospective Diabetes Study (UKPDS), define autoimmunity in type 2 diabetic subjects based solely on autoantibody positivity (24).”
Improved T cell assay for identification of type 1 diabetes patients
Brooks‐Worrell, B., Warsen, A., & Palmer, J. P. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.03.004 · Cited by 18 · cited 1×
“We are, however, working to optimize and scale down cellular immunoblotting (23), so that this technique may be more applicable to future clinical trials.”
Self-citationImmunological aspects of ‘fulminant type 1 diabetes’
Nagata, M., Moriyama, H., Kotani, R., Yasuda, H., Kishi, M., Kurohara, M., Hara, K., & Yokono, K. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.041 · Cited by 12 · cited 1×
“Furthermore, patients with fulminant type 1 diabetes have been reported to be autoantibody negative but demonstrate islet-specific T-cell responses (8).”
Research works printed but not linked: 1
- Ringquist, 2007, Transplantation genetics, 983
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus
Akash, M. S. H., Rehman, K., & Chen, S. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24402 · Cited by 407
“Interestingly, other than these determinants, recently autoimmune participants causing inflammation have been also considered playing their role in insulin resistance by affecting b-cells of pancreatic islets [Brooks-Worrell et al., 2011; Goldfine et al., 2011].”
BackgroundAdult-onset autoimmune diabetes: current knowledge and implications for management
Buzzetti, R., Zampetti, S., & Maddaloni, E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.99 · Cited by 271
“Furthermore, a new autoantibody against the extracytoplasmatic (EC) IA-2EC(26-577) region can identify a novel antigenic determinant within the N terminus of the IA-2 protein76.”
BackgroundDiabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
Leslie, R. D., Palmer, J., Schloot, N. C., & Lernmark, A. (2016) · Diabetologia · doi:10.1007/s00125-015-3789-z · Cited by 204
Self-citationDiabetes and beta cell function: from mechanisms to evaluation and clinical implications
Cernea, S., & Dobreanu, M. (2013) · Biochemia Medica · doi:10.11613/bm.2013.033 · Cited by 203
“Some phenotypic T2DM subjects also present markers of autoimmunity and these are correlated with beta cell function, suggesting a possible role of immune system in the pathogenesis of T2DM (4,40,41).”
Background
Metadata
- Authors
- Brooks-Worrell, B. M., Reichow, J. L., Goel, A., Ismail, H., & Palmer, J. P.
- Affiliations
- Department of Medicine, University of Washington, Seattle, Washington;
- Seattle Institute for Biomedical and Clinical Research (US)
- Bronx-Lebanon Hospital Center (US)
- Cairo University (EG)
- United States Department of Veterans Affairs (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-09-20
- Volume
- 34
- Issue
- 1
- Pages
- 168-173
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3004952
- OpenAlex
- W2033958293
- Cited by
- 83
- References
- 28
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 2 · 2022: 9 · 2021: 5 · 2020: 3 · 2019: 7 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 11 · 2014: 10 · 2013: 9 · 2012: 8
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- GlaxoSmithKline
- University of Florida
- University of Washington
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK053004, P30DK017047)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 2 diabetes, islet autoimmunity, islet autoantibodies, beta-cell function, C-peptide response, GAD65 antibodies, insulin autoantibodies, diabetes subgroups
- MeSH terms
- Adult, Aged, Autoantibodies, C-Peptide, Diabetes Mellitus, Type 2, Haplotypes, Humans, Insulin Resistance, Middle Aged, T-Lymphocytes, Immunoblotting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.